To provide opportunity for encouragement, Phoenix-based Associated Retina Consultants, in coordination with the International ...

Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events were ...

It’s been eight months since Regeneron secured approval for a high-dose version of its powerhouse macular degeneration ...

DelveInsight's Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current ...

Both macular degeneration and glaucoma can lead to vision loss and blindness. But they have different causes and treatments. Age-related macular degeneration (AMD) and glaucoma are two of the most ...

Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma ...

AMD Stopper Inc. is a newly organized company which holds the formulas, patent applications, and intellectual property rights to the formula developed by an eye care researcher to treat Age-Related ...

Several companies are experimenting with optogenetics to create a “bionic eye” that can restore sight in visually impaired people.

Brain-computer interface developer Science Corporation acquired the IP and related assets for the Pixium Vision Prima implant ...

I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration (AMD). I have just had my second round of Eyelea, and with the pollen starting up, my eyes are ...